P1, N=20, Active, not recruiting, Alessa Therapeutics Inc. | Trial completion date: Dec 2024 --> Aug 2027 | Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2024 --> May 2027
7 months ago
Enrollment closed • Trial completion date • Trial primary completion date